U S PHYSICAL THERAPY INC /NV (USPH) Operating Margin
- Operating margin · 12 months: Value 9.42%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 9.42% | Operating income / revenue. Period ending 2026-06-30. $76.52M ÷ $812.20M × 100 ≈ 9.42% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 76.52M USD | Operating Income (Loss) |
| Revenue | 812.20M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 72.82M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76.52M | $812.20M | (m) | (m) | $72.82M | 9.42% |
| 2026-03-31 | $79.52M | $795.49M | (m) | (m) | $71.29M | 10.00% |
| 2025-12-31 | $86.68M | $780.99M | (m) | (m) | $69.26M | 11.10% |
| 2025-09-30 | $89.78M | $758.71M | (m) | (m) | $66.71M | 11.83% |
| 2025-06-30 | $77.30M | $729.61M | (m) | (m) | $63.68M | 10.59% |
| 2025-03-31 | $67.93M | $699.46M | (m) | (m) | $60.45M | 9.71% |
| 2024-12-31 | $63.21M | $671.35M | (m) | (m) | $58.29M | 9.42% |
| 2024-09-30 | $47.80M | $645.70M | (m) | (m) | $56.62M | 7.40% |
| 2024-06-30 | $48.93M | $627.67M | (m) | (m) | $54.28M | 7.80% |
| 2024-03-31 | $49.38M | $611.97M | (m) | (m) | $52.18M | 8.07% |
| 2023-12-31 | $52.06M | $604.80M | (m) | (m) | $51.95M | 8.61% |
| 2023-09-30 | $59.73M | $591.18M | (m) | (m) | $49.98M | 10.10% |
| 2023-06-30 | $58.75M | $580.78M | (m) | (m) | $49.82M | 10.12% |
| 2023-03-31 | $58.77M | $569.95M | (m) | (m) | $48.41M | 10.31% |
| 2022-12-31 | $56.80M | $553.14M | (m) | (m) | $46.11M | 10.27% |
| 2022-09-30 | $66.47M | $541.79M | (m) | (m) | $44.90M | 12.27% |
| 2022-06-30 | $68.51M | $528.09M | (m) | (m) | $45.88M | 12.97% |
| 2022-03-31 | $70.66M | $514.36M | (m) | (m) | $47.22M | 13.74% |
| 2021-12-31 | $70.65M | $495.02M | (m) | (m) | $46.53M | 14.27% |
| 2021-09-30 | $72.39M | $482.65M | (m) | (m) | $46.73M | 15.00% |
| 2021-06-30 | $75.39M | $465.69M | (m) | (m) | $44.29M | 16.19% |
| 2021-03-31 | $63.42M | $422.62M | (m) | (m) | $41.23M | 15.01% |
| 2020-12-31 | $52.41M | $422.97M | (m) | (m) | $42.04M | 12.39% |
| 2020-09-30 | $49.50M | $427.62M | (m) | (m) | $42.79M | 11.58% |
| 2020-06-30 | $46.38M | $435.94M | (m) | (m) | $42.93M | 10.64% |
| 2020-03-31 | $56.01M | $478.45M | (m) | (m) | $45.43M | 11.71% |
| 2019-12-31 | $67.42M | $481.97M | (m) | (m) | $45.05M | 13.99% |
| 2019-09-30 | $66.94M | $477.20M | (m) | (m) | $43.79M | 14.03% |
| 2019-06-30 | $65.56M | $473.07M | (m) | (m) | $43.88M | 13.86% |
| 2019-03-31 | $62.69M | $461.80M | (m) | (m) | $42.48M | 13.57% |
| 2018-12-31 | $60.31M | $453.91M | (m) | (m) | $41.35M | 13.29% |
| 2018-09-30 | $59.47M | $445.76M | (m) | (m) | $41.12M | 13.34% |
| 2018-06-30 | $56.93M | $435.68M | (m) | (m) | $38.78M | 13.07% |
| 2018-03-31 | $55.58M | $424.83M | (m) | (m) | $37.51M | 13.08% |
| 2017-12-31 | $54.73M | $414.05M | (m) | (m) | $35.89M | 13.22% |
| 2017-09-30 | $51.72M | $395.71M | (m) | (m) | $33.55M | 13.07% |
| 2017-06-30 | $50.89M | $381.02M | (m) | (m) | $32.85M | 13.36% |
| 2017-03-31 | $50.24M | $367.20M | (m) | (m) | $32.02M | 13.68% |
| 2016-12-31 | $49.53M | $356.55M | (m) | (m) | $32.48M | 13.89% |
| 2016-09-30 | $51.19M | $352.41M | (m) | (m) | $33.53M | 14.53% |
| 2016-06-30 | $51.08M | $348.11M | (m) | (m) | $32.85M | 14.67% |
| 2016-03-31 | $49.60M | $340.97M | (m) | (m) | $32.41M | 14.55% |
| 2015-12-31 | $47.29M | $331.30M | (m) | (m) | $31.07M | 14.28% |
| 2015-09-30 | $45.44M | $323.97M | (m) | (m) | (m) | 14.03% |
| 2015-06-30 | $44.77M | $317.63M | (m) | (m) | (m) | 14.09% |
| 2015-03-31 | $45.44M | $312.55M | (m) | (m) | (m) | 14.54% |
| 2014-12-31 | $45.77M | $305.07M | (m) | (m) | (m) | 15.00% |
| 2014-09-30 | $44.38M | $294.29M | (m) | (m) | (m) | 15.08% |
| 2014-06-30 | $43.01M | $282.40M | (m) | (m) | (m) | 15.23% |
| 2014-03-31 | $39.85M | $271.07M | (m) | (m) | (m) | 14.70% |
| 2013-12-31 | $38.77M | $264.06M | (m) | (m) | (m) | 14.68% |
| 2013-09-30 | $37.10M | $260.27M | (m) | (m) | (m) | 14.25% |
| 2013-06-30 | $36.17M | $255.87M | (m) | (m) | (m) | 14.14% |
| 2013-03-31 | $36.08M | $252.60M | (m) | (m) | (m) | 14.28% |
| 2012-12-31 | $37.80M | $252.09M | (m) | (m) | (m) | 15.00% |
| 2012-09-30 | $37.58M | $250.07M | (m) | (m) | (m) | 15.03% |
| 2012-06-30 | $36.84M | $246.89M | (m) | (m) | (m) | 14.92% |
| 2012-03-31 | $37.12M | $242.85M | (m) | (m) | (m) | 15.29% |
| 2011-12-31 | $35.93M | $237.01M | (m) | (m) | (m) | 15.16% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $33.19M | $211.23M | (m) | (m) | (m) | 15.71% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $28.25M | $201.41M | (m) | (m) | (m) | 14.03% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |